Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques-Reference-Cited by-同舟云学术

Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques

Published:2020-09-16 Issue:12 Volume:45 Page:4273-4289
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Wang Zhen J.^ORCID,Arif-Tiwari Hina,Zaheer Atif,Ameli Sanaz,Bhosale Priya R.,Do Richard K.,Goenka Ajit H.,Guimares Alexander R.,Sangster Guillermo P.,Soloff Erik V.,Tamm Eric P.,Zins Marc,Kambadakone Avinash R.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-020-02723-z.pdf

Reference87 articles.

1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research. 2014;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155. PubMed PMID: 24840647.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. Epub 2019/01/09. https://doi.org/10.3322/caac.21551. PubMed PMID: 30620402.

3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. Epub 2011/02/08. https://doi.org/10.3322/caac.20107. PubMed PMID: 21296855.

4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29. Epub 2012/01/13. https://doi.org/10.3322/caac.20138. PubMed PMID: 22237781.

5. Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, et al. Pancreatic Adenocarcinoma, Version 1.2019. J Natl Compr Canc Netw. 2019;17(3):202-10. Epub 2019/03/14. https://doi.org/10.6004/jnccn.2019.0014. PubMed PMID: 30865919.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how;World Journal of Gastrointestinal Surgery;2024-05-27

2. Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers;Annals of Surgical Oncology;2024-02-17

3. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy;Cancer Research and Treatment;2024-01-15

4. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer;Nature Reviews Gastroenterology & Hepatology;2023-11-30

5. Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs;Pancreatology;2023-08